Article | August 13, 2017

Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation

Source: Patheon – Part Of Thermo Fisher Scientific

Anil Kane, Ph.D., MBA, Global Head of Technical and Scientific Affairs, Formulation

Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation

Molecules continue to get more challenging from the perspective of solubility, bioavailability, and exposure. Advances in formulation technologies continue to provide more solutions. Establishing effective communications between DS chemists and DP formulators manage the risks and maximize the rewards of transforming less soluble and less bioavailable molecules into effective new drugs.

Patheon – Part Of Thermo Fisher Scientific